Enhancement of radiation cytotoxicity in murine cancer cells by electroporation: in vitro and in vivo studies.
Increasing evidence has accumulated in recent years to suggest that the cell membrane forms the vital common target for action by ionizing radiation and electroporation. The present work describes the use of electric pulses for enhancement of radiation-induced cytotoxicity of cancer cells both in vitro and in vivo. In vitro: low dose rate (0.37 Gy/min) Co60 gamma-rays (2 Gy) in combination with electric pulses of square wave (2 kV/cm, 200 micros duration, 8 pulses/burst, 10 times) significantly enhanced the cytotoxicity in Ehrlich ascites carcinoma cells (EAC), probably through enhanced production of intracellular reactive oxygen species (ROS). The intracellular generation of ROS and changes in oxidative damage-mediated membrane fluidity were determined by fluorescence using DCH-FDA and DPH, respectively, as probes. Both radiation and electroporation, separately, have been observed to produce ROS in a dose-dependent fashion. We show that the combined treatment of cells with radiation and electroporation significantly increased intracellular ROS and changed membrane fluidity of EAC cells as compared to the effects by each individual treatment. In vivo studies have been carried out with murine fibrosarcoma as a model system. The localized treatment of a fibrosarcoma tumor, grown in the right hind leg of Swiss mice, had been carried out using radiation (Co60 gamma-rays, 2 Gy, dose rate: 0.37 Gy/min) and electric pulses (1 kV/cm, 200 micros, 8 pulses/burst, 10 times). Studies on tumor growth kinetics have shown a significant growth delay (by 50% to that of control) 7 days after treatment of tumor with radiation and electroporation. The results suggest that radiocytotoxicity of tumor cells in vitro as well as in vivo were enhanced significantly by electric pulses, which may offer a potentially improved treatment of cancer.
Shil
Pratip
P
Biophysics Laboratory, Department of Physics, University of Pune, Pune, India.
Sanghvi
Surendra H
SH
Vidyasagar
Pandit B
PB
Mishra
Kaushala P
KP
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism / Q000473:pathology*; D016923:Cell Death / Q000528:radiation effects*; D045744:Cell Line, Tumor; D002470:Cell Survival; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D018274:Electroporation; D005354:Fibrosarcoma / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D005720:Gamma Rays; D008560:Membrane Fluidity / Q000528:radiation effects; D051379:Mice; D009368:Neoplasm Transplantation; D018384:Oxidative Stress / Q000528:radiation effects; D017382:Reactive Oxygen Species / Q000378:metabolism
D017382:Reactive Oxygen Species